Addenda Capital Inc. Gilead Sciences, Inc. Transaction History

Addenda Capital Inc.

$2.04 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 08, 2021	SELL	$67.69 - $73.03 $2.08 Million - $2.25 Million	-30,780 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$63.47 - $69.35 $930,724 - $1.02 Million	-14,664 Reduced 32.27%	30,780 $2.12 Million
Q4 2020 Jan 19, 2021	SELL	$56.65 - $64.55 $23,453 - $26,723	-414 Reduced 0.9%	45,444 $2.65 Million
Q3 2020 Oct 15, 2020	SELL	$62.1 - $78.08 $94,143 - $118,369	-1,516 Reduced 3.2%	45,858 $2.9 Million
Q2 2020 Jul 09, 2020	SELL	$72.34 - $84.0 $199,658 - $231,840	-2,760 Reduced 5.51%	47,374 $3.64 Million
Q1 2020 Apr 13, 2020	SELL	$62.63 - $80.22 $237,994 - $304,836	-3,800 Reduced 7.05%	50,134 $3.75 Million
Q4 2019 Jan 31, 2020	BUY	$61.62 - $67.78 $157,993 - $173,787	2,564 Added 4.99%	53,934 $3.5 Million
Q3 2019 Oct 08, 2019	SELL	$62.51 - $69.0 $11,626 - $12,834	-186 Reduced 0.36%	51,370 $3.26 Million
Q2 2019 Jul 12, 2019	SELL	$61.87 - $69.38 $731,117 - $819,863	-11,817 Reduced 18.65%	51,556 $3.48 Million
Q1 2019 Apr 09, 2019	BUY	$62.53 - $70.05 $227,734 - $255,122	3,642 Added 6.1%	63,373 $4.12 Million
Q4 2018 Jan 14, 2019	BUY	$60.54 - $79.0 $82,455 - $107,598	1,362 Added 2.33%	59,731 $3.74 Million
Q3 2018 Oct 16, 2018	SELL	$71.28 - $78.92 $1.12 Million - $1.24 Million	-15,754 Reduced 21.25%	58,369 $4.51 Million
Q2 2018 Jul 13, 2018	SELL	$64.88 - $75.68 $5.26 Million - $6.13 Million	-81,019 Reduced 52.22%	74,123 $5.25 Million
Q2 2018 Jul 12, 2018	BUY	$64.88 - $75.68 $4.81 Million - $5.61 Million	74,123 Added 91.49%	155,142 $11.4 Million
Q1 2018 Apr 11, 2018	SELL	$72.84 - $88.8 $174,524 - $212,764	-2,396 Reduced 2.87%	81,019 $6.11 Million
Q4 2017 Jan 12, 2018	SELL	$71.15 - $83.52 $412,670 - $484,416	-5,800 Reduced 6.5%	83,415 $5.97 Million
Q3 2017 Oct 11, 2017	BUY	$72.11 - $85.47 $6.43 Million - $7.63 Million	89,215	89,215 $7.23 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Addenda Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Addenda Capital Inc. with notifications on news.

Account